Share Price and Basic Stock Data
Last Updated: October 26, 2025, 8:43 am
| PEG Ratio | 3.58 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
ICRA Ltd, a prominent player in the rating services industry, reported a share price of ₹6,348 and a market capitalization of ₹6,127 Cr. The company has shown robust growth in its sales, which stood at ₹403 Cr for the fiscal year ending March 2023, reflecting an increase from ₹343 Cr in March 2022. By March 2025, sales are projected to rise further to ₹498 Cr, demonstrating a consistent upward trajectory. Quarterly sales figures also illustrate this trend, with the most recent quarter ending June 2025 recording ₹124 Cr. This growth has been supported by a healthy operating profit margin (OPM) of 36% for the fiscal year 2025, suggesting effective cost management alongside revenue growth. The company’s focus on maintaining strong revenue streams is evident as it continues to capture market share in the competitive rating services sector, with a significant increase in total sales over the years. The trailing twelve months (TTM) revenue reached ₹508 Cr, indicating a solid performance in recent quarters.
Profitability and Efficiency Metrics
ICRA’s profitability metrics reflect a solid operational framework, with a reported net profit of ₹171 Cr for the fiscal year ending March 2025, up from ₹137 Cr in March 2023. The net profit margin stood at 34.37% for the same period, showcasing the company’s ability to convert a significant portion of revenue into profit. The return on equity (ROE) was recorded at 16.8%, while the return on capital employed (ROCE) reached 23.1%, both indicating efficient use of equity and capital. The interest coverage ratio (ICR) was an impressive 53.12x, suggesting that ICRA comfortably meets its interest obligations. This financial strength is complemented by an operating profit of ₹178 Cr for FY 2025, with an OPM of 36%. However, the company did experience a decline in operating profit margin to 26% in the December 2023 quarter, highlighting potential challenges in managing operating expenses amid rising costs.
Balance Sheet Strength and Financial Ratios
ICRA Ltd’s balance sheet reflects a strong financial position, with total reserves amounting to ₹1,044 Cr as of March 2025, up from ₹941 Cr in March 2023. The company maintained low borrowings of ₹13 Cr, indicating a conservative approach to debt and a strong equity base. The debt-to-equity ratio is minimal, which enhances financial stability and reduces risk. The current ratio stood at 6.37, well above the typical sector benchmark, indicating excellent short-term liquidity. The price-to-book value (P/BV) ratio was reported at 5.06x, suggesting that the stock is trading at a premium relative to its book value, reflecting investor confidence. Additionally, the company’s ability to generate cash is evident from a cash EPS of ₹194.38, further demonstrating its operational efficiency. However, the enterprise value (EV) to net operating revenue ratio of 10.15x indicates a relatively high valuation in comparison to revenue, which could be a concern for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of ICRA Ltd indicates a stable ownership structure, with promoters holding 51.86% of the shares as of March 2025. This significant stake reflects strong management confidence in the company’s future prospects. Foreign institutional investors (FIIs) held 6.87% of the shares, while domestic institutional investors (DIIs) accounted for 26.15%, indicating robust institutional interest. The total number of shareholders has grown to 21,818, up from 17,046 in June 2023, showcasing increasing retail investor participation and confidence. The consistent dividend payout ratio of 34.37% for FY 2025 further enhances attractiveness to income-focused investors. However, the slight decrease in FII holdings from 8.78% in March 2025 could suggest a cautious sentiment among foreign investors. Overall, the stable promoter holding and increasing retail participation imply a positive outlook for investor confidence in ICRA Ltd.
Outlook, Risks, and Final Insight
ICRA Ltd is well-positioned for continued growth in the rating services sector, supported by strong revenue trends and profitability metrics. The company’s efficient operations and low debt levels contribute to its financial resilience. However, challenges such as fluctuating operating margins and high valuation ratios may pose risks going forward. Additionally, external factors such as regulatory changes and market competition could impact future performance. The company’s focus on maintaining a healthy balance sheet and adapting to market dynamics will be crucial for sustaining growth. As ICRA navigates these challenges, its ability to leverage its market position and operational strengths will determine its long-term success. An emphasis on innovation and customer engagement could further enhance its competitive edge, ensuring that it remains a leader in the rating services industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of ICRA Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 6,033 Cr. | 6,251 | 7,413/5,015 | 34.1 | 1,091 | 0.96 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,748 Cr. | 1,582 | 1,965/1,052 | 33.4 | 269 | 1.14 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,390.50 Cr | 3,916.50 | 33.75 | 680.00 | 1.05% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93 | 99 | 103 | 109 | 103 | 105 | 115 | 124 | 115 | 126 | 121 | 136 | 124 |
| Expenses | 61 | 63 | 67 | 71 | 68 | 71 | 84 | 74 | 80 | 85 | 79 | 77 | 85 |
| Operating Profit | 32 | 36 | 36 | 38 | 35 | 34 | 30 | 50 | 35 | 41 | 42 | 59 | 40 |
| OPM % | 34% | 36% | 35% | 35% | 34% | 32% | 26% | 40% | 31% | 33% | 35% | 43% | 32% |
| Other Income | 7 | 13 | 15 | 16 | 18 | 16 | 17 | 24 | 18 | 20 | 19 | 21 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 2 | 0 | 1 | 1 | 2 |
| Depreciation | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 36 | 46 | 48 | 51 | 50 | 47 | 41 | 62 | 47 | 57 | 56 | 74 | 58 |
| Tax % | 41% | 19% | 18% | 24% | 18% | 32% | 20% | 24% | 24% | 35% | 24% | 24% | 27% |
| Net Profit | 22 | 37 | 39 | 39 | 41 | 32 | 32 | 47 | 36 | 37 | 42 | 56 | 43 |
| EPS in Rs | 22.02 | 38.06 | 40.29 | 39.76 | 41.77 | 32.92 | 33.31 | 48.56 | 36.80 | 38.05 | 43.55 | 57.75 | 43.97 |
Last Updated: August 1, 2025, 7:45 pm
Below is a detailed analysis of the quarterly data for ICRA Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 12.00 Cr..
- For Expenses, as of Jun 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2025) to 85.00 Cr., marking an increase of 8.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 32.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 32.00%, marking a decrease of 11.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 16.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 27.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 43.97. The value appears to be declining and may need further review. It has decreased from 57.75 (Mar 2025) to 43.97, marking a decrease of 13.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 6:02 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 283 | 322 | 341 | 333 | 309 | 328 | 321 | 301 | 343 | 403 | 446 | 498 | 508 |
| Expenses | 197 | 252 | 240 | 231 | 194 | 215 | 225 | 220 | 222 | 260 | 297 | 320 | 325 |
| Operating Profit | 86 | 70 | 101 | 102 | 115 | 113 | 96 | 81 | 121 | 143 | 149 | 178 | 182 |
| OPM % | 30% | 22% | 30% | 31% | 37% | 34% | 30% | 27% | 35% | 35% | 33% | 36% | 36% |
| Other Income | 19 | 42 | 27 | 39 | 49 | 45 | 48 | 43 | 41 | 50 | 75 | 77 | 84 |
| Interest | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 10 | 5 | 4 |
| Depreciation | 6 | 10 | 10 | 9 | 8 | 6 | 10 | 10 | 8 | 10 | 13 | 16 | 17 |
| Profit before tax | 98 | 100 | 118 | 132 | 157 | 152 | 131 | 112 | 152 | 181 | 200 | 234 | 245 |
| Tax % | 30% | 35% | 35% | 33% | 35% | 30% | 26% | 26% | 25% | 25% | 24% | 27% | |
| Net Profit | 69 | 66 | 76 | 89 | 101 | 106 | 97 | 83 | 114 | 137 | 152 | 171 | 178 |
| EPS in Rs | 68.93 | 65.45 | 76.24 | 89.29 | 101.68 | 109.21 | 99.66 | 84.61 | 116.35 | 140.13 | 156.55 | 176.15 | 183.32 |
| Dividend Payout % | 33% | 37% | 33% | 30% | 29% | 27% | 27% | 32% | 24% | 93% | 64% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.35% | 15.15% | 17.11% | 13.48% | 4.95% | -8.49% | -14.43% | 37.35% | 20.18% | 10.95% | 12.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.50% | 1.95% | -3.62% | -8.53% | -13.44% | -5.94% | 51.78% | -17.17% | -9.23% | 1.55% |
ICRA Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 15% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 6:45 am
Balance Sheet
Last Updated: July 25, 2025, 3:03 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 378 | 419 | 466 | 539 | 645 | 631 | 692 | 748 | 834 | 941 | 967 | 1,044 |
| Borrowings | 16 | 10 | 0 | 0 | 0 | 0 | 0 | 17 | 14 | 13 | 13 | 13 |
| Other Liabilities | 109 | 144 | 151 | 111 | 116 | 128 | 144 | 121 | 121 | 138 | 195 | 225 |
| Total Liabilities | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 |
| Fixed Assets | 89 | 91 | 92 | 37 | 36 | 34 | 54 | 46 | 46 | 47 | 91 | 90 |
| CWIP | 7 | 0 | 1 | 1 | 0 | 1 | 2 | 3 | 2 | 1 | 1 | 4 |
| Investments | 277 | 257 | 185 | 311 | 338 | 182 | 104 | 177 | 454 | 689 | 813 | 773 |
| Other Assets | 140 | 234 | 350 | 312 | 396 | 552 | 685 | 669 | 478 | 364 | 278 | 426 |
| Total Assets | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 |
Below is a detailed analysis of the balance sheet data for ICRA Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,044.00 Cr.. The value appears strong and on an upward trend. It has increased from 967.00 Cr. (Mar 2024) to 1,044.00 Cr., marking an increase of 77.00 Cr..
- For Borrowings, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 225.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 195.00 Cr. (Mar 2024) to 225.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,292.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,184.00 Cr. (Mar 2024) to 1,292.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 90.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Mar 2024) to 90.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 813.00 Cr. (Mar 2024) to 773.00 Cr., marking a decrease of 40.00 Cr..
- For Other Assets, as of Mar 2025, the value is 426.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2024) to 426.00 Cr., marking an increase of 148.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,292.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,184.00 Cr. (Mar 2024) to 1,292.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (1,044.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 60.00 | 101.00 | 102.00 | 115.00 | 113.00 | 96.00 | 64.00 | 107.00 | 130.00 | 136.00 | 165.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Working Capital Days | -54 | -64 | -66 | -45 | -41 | -44 | -2 | -48 | -55 | -64 | -61 | -75 |
| ROCE % | 23% | 21% | 24% | 26% | 25% | 23% | 20% | 15% | 19% | 20% | 21% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 422,587 | 0.42 | 232.17 | 422,587 | 2025-04-22 17:25:32 | 0% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 282,810 | 1.04 | 155.37 | 282,810 | 2025-04-22 15:56:57 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 271,257 | 4.15 | 149.03 | 271,257 | 2025-04-22 15:56:57 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 271,257 | 4.15 | 149.03 | 271,257 | 2025-04-22 15:56:57 | 0% |
| Canara Robeco Small Cap Fund | 168,320 | 0.96 | 92.47 | 168,320 | 2025-04-22 15:56:57 | 0% |
| Mahindra Manulife Small Cap Fund | 88,605 | 1.39 | 48.68 | 88,605 | 2025-04-22 17:25:32 | 0% |
| Sundaram Small Cap Fund | 85,868 | 1.54 | 47.18 | 85,868 | 2025-04-22 15:56:57 | 0% |
| Sundaram Diversified Equity Fund | 58,000 | 1.99 | 31.86 | 58,000 | 2025-04-22 17:25:32 | 0% |
| Sundaram Flexicap Fund | 46,000 | 1.22 | 25.27 | 46,000 | 2025-04-22 15:56:57 | 0% |
| Sundaram Focused Fund | 43,000 | 2.38 | 23.62 | 43,000 | 2025-04-22 15:56:57 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 176.73 | 157.07 | 140.59 | 116.74 | 84.89 |
| Diluted EPS (Rs.) | 176.50 | 156.99 | 140.59 | 116.74 | 84.89 |
| Cash EPS (Rs.) | 194.38 | 171.69 | 151.85 | 125.73 | 95.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Revenue From Operations / Share (Rs.) | 516.02 | 462.24 | 417.80 | 355.19 | 311.94 |
| PBDIT / Share (Rs.) | 264.39 | 231.82 | 199.41 | 167.29 | 128.46 |
| PBIT / Share (Rs.) | 247.40 | 217.87 | 189.23 | 159.20 | 118.18 |
| PBT / Share (Rs.) | 242.43 | 207.08 | 187.77 | 157.58 | 116.05 |
| Net Profit / Share (Rs.) | 177.39 | 157.74 | 141.67 | 117.64 | 85.67 |
| NP After MI And SOA / Share (Rs.) | 176.15 | 156.56 | 140.12 | 116.35 | 84.61 |
| PBDIT Margin (%) | 51.23 | 50.15 | 47.72 | 47.09 | 41.18 |
| PBIT Margin (%) | 47.94 | 47.13 | 45.29 | 44.82 | 37.88 |
| PBT Margin (%) | 46.98 | 44.80 | 44.94 | 44.36 | 37.20 |
| Net Profit Margin (%) | 34.37 | 34.12 | 33.90 | 33.11 | 27.46 |
| NP After MI And SOA Margin (%) | 34.13 | 33.86 | 33.53 | 32.75 | 27.12 |
| Return on Networth / Equity (%) | 16.14 | 15.47 | 14.23 | 13.31 | 10.77 |
| Return on Capital Employeed (%) | 21.37 | 20.30 | 18.84 | 17.80 | 14.62 |
| Return On Assets (%) | 13.13 | 12.72 | 12.28 | 11.47 | 9.11 |
| Asset Turnover Ratio (%) | 0.40 | 0.38 | 0.24 | 0.23 | 0.23 |
| Current Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Quick Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Dividend Payout Ratio (NP) (%) | 56.58 | 82.76 | 19.91 | 23.12 | 31.80 |
| Dividend Payout Ratio (CP) (%) | 51.60 | 75.99 | 18.56 | 21.62 | 28.36 |
| Earning Retention Ratio (%) | 43.42 | 17.24 | 80.09 | 76.88 | 68.20 |
| Cash Earning Retention Ratio (%) | 48.40 | 24.01 | 81.44 | 78.38 | 71.64 |
| Interest Coverage Ratio (X) | 53.12 | 21.50 | 136.25 | 103.41 | 60.27 |
| Interest Coverage Ratio (Post Tax) (X) | 36.64 | 15.63 | 97.80 | 73.71 | 41.19 |
| Enterprise Value (Cr.) | 5054.70 | 5105.59 | 4025.55 | 3803.03 | 2773.34 |
| EV / Net Operating Revenue (X) | 10.15 | 11.44 | 9.98 | 11.09 | 9.21 |
| EV / EBITDA (X) | 19.81 | 22.82 | 20.92 | 23.55 | 22.37 |
| MarketCap / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| Retention Ratios (%) | 43.41 | 17.23 | 80.08 | 76.87 | 68.19 |
| Price / BV (X) | 5.06 | 5.38 | 4.49 | 4.87 | 4.18 |
| Price / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
After reviewing the key financial ratios for ICRA Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 176.73. This value is within the healthy range. It has increased from 157.07 (Mar 24) to 176.73, marking an increase of 19.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 176.50. This value is within the healthy range. It has increased from 156.99 (Mar 24) to 176.50, marking an increase of 19.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 194.38. This value is within the healthy range. It has increased from 171.69 (Mar 24) to 194.38, marking an increase of 22.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 516.02. It has increased from 462.24 (Mar 24) to 516.02, marking an increase of 53.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 264.39. This value is within the healthy range. It has increased from 231.82 (Mar 24) to 264.39, marking an increase of 32.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.40. This value is within the healthy range. It has increased from 217.87 (Mar 24) to 247.40, marking an increase of 29.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 242.43. This value is within the healthy range. It has increased from 207.08 (Mar 24) to 242.43, marking an increase of 35.35.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 177.39. This value is within the healthy range. It has increased from 157.74 (Mar 24) to 177.39, marking an increase of 19.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 176.15. This value is within the healthy range. It has increased from 156.56 (Mar 24) to 176.15, marking an increase of 19.59.
- For PBDIT Margin (%), as of Mar 25, the value is 51.23. This value is within the healthy range. It has increased from 50.15 (Mar 24) to 51.23, marking an increase of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 47.94. This value exceeds the healthy maximum of 20. It has increased from 47.13 (Mar 24) to 47.94, marking an increase of 0.81.
- For PBT Margin (%), as of Mar 25, the value is 46.98. This value is within the healthy range. It has increased from 44.80 (Mar 24) to 46.98, marking an increase of 2.18.
- For Net Profit Margin (%), as of Mar 25, the value is 34.37. This value exceeds the healthy maximum of 10. It has increased from 34.12 (Mar 24) to 34.37, marking an increase of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.13. This value exceeds the healthy maximum of 20. It has increased from 33.86 (Mar 24) to 34.13, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has increased from 15.47 (Mar 24) to 16.14, marking an increase of 0.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.37. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 21.37, marking an increase of 1.07.
- For Return On Assets (%), as of Mar 25, the value is 13.13. This value is within the healthy range. It has increased from 12.72 (Mar 24) to 13.13, marking an increase of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.38 (Mar 24) to 0.40, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Quick Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 2. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 56.58. This value exceeds the healthy maximum of 50. It has decreased from 82.76 (Mar 24) to 56.58, marking a decrease of 26.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 51.60. This value exceeds the healthy maximum of 50. It has decreased from 75.99 (Mar 24) to 51.60, marking a decrease of 24.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 43.42. This value is within the healthy range. It has increased from 17.24 (Mar 24) to 43.42, marking an increase of 26.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 48.40. This value is within the healthy range. It has increased from 24.01 (Mar 24) to 48.40, marking an increase of 24.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.12. This value is within the healthy range. It has increased from 21.50 (Mar 24) to 53.12, marking an increase of 31.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.64. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 36.64, marking an increase of 21.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,054.70. It has decreased from 5,105.59 (Mar 24) to 5,054.70, marking a decrease of 50.89.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.15. This value exceeds the healthy maximum of 3. It has decreased from 11.44 (Mar 24) to 10.15, marking a decrease of 1.29.
- For EV / EBITDA (X), as of Mar 25, the value is 19.81. This value exceeds the healthy maximum of 15. It has decreased from 22.82 (Mar 24) to 19.81, marking a decrease of 3.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For Retention Ratios (%), as of Mar 25, the value is 43.41. This value is within the healthy range. It has increased from 17.23 (Mar 24) to 43.41, marking an increase of 26.18.
- For Price / BV (X), as of Mar 25, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.38 (Mar 24) to 5.06, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ICRA Ltd:
- Net Profit Margin: 34.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.37% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.14% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 36.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.1 (Industry average Stock P/E: 33.75)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | B-710, Statesman House, New Delhi Delhi 110001 | investors@icraindia.com http://www.icra.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Palamadai Sundararajan Jayakumar | Non Exe.Chairman&Ind.Director |
| Mr. Ramnath Krishnan | Managing Director & Group CEO |
| Ms. Wendy Huay Huay Cheong | Non Exe.Non Ind.Director |
| Ms. Shivani Priya Mohini Kak | Non Exe.Non Ind.Director |
| Mr. Stephen Arthur Long | Non Exe.Non Ind.Director |
| Mr. Brian Joseph Cahill | Non Exe.Non Ind.Director |
| Mr. Pradip Kanakia | Independent Director |
| Ms. Anuranjita Kumar | Independent Director |
FAQ
What is the intrinsic value of ICRA Ltd?
ICRA Ltd's intrinsic value (as of 26 October 2025) is 5048.10 which is 19.24% lower the current market price of 6,251.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,033 Cr. market cap, FY2025-2026 high/low of 7,413/5,015, reserves of ₹1,044 Cr, and liabilities of 1,292 Cr.
What is the Market Cap of ICRA Ltd?
The Market Cap of ICRA Ltd is 6,033 Cr..
What is the current Stock Price of ICRA Ltd as on 26 October 2025?
The current stock price of ICRA Ltd as on 26 October 2025 is 6,251.
What is the High / Low of ICRA Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ICRA Ltd stocks is 7,413/5,015.
What is the Stock P/E of ICRA Ltd?
The Stock P/E of ICRA Ltd is 34.1.
What is the Book Value of ICRA Ltd?
The Book Value of ICRA Ltd is 1,091.
What is the Dividend Yield of ICRA Ltd?
The Dividend Yield of ICRA Ltd is 0.96 %.
What is the ROCE of ICRA Ltd?
The ROCE of ICRA Ltd is 23.1 %.
What is the ROE of ICRA Ltd?
The ROE of ICRA Ltd is 16.8 %.
What is the Face Value of ICRA Ltd?
The Face Value of ICRA Ltd is 10.0.